Ryan Brinkman

Stock Analyst at JP Morgan

(2.46)
# 2,358
Out of 5,182 analysts
292
Total ratings
50.75%
Success rate
-2.41%
Average return

Stocks Rated by Ryan Brinkman

The Goodyear Tire & Rubber Company
Apr 23, 2026
Maintains: Overweight
Price Target: $11$10
Current: $7.14
Upside: +40.06%
Visteon
Apr 23, 2026
Maintains: Neutral
Price Target: $110$108
Current: $113.14
Upside: -4.54%
Magna International
Apr 23, 2026
Maintains: Overweight
Price Target: $71$70
Current: $62.28
Upside: +12.40%
Gentherm
Apr 23, 2026
Maintains: Neutral
Price Target: $42$37
Current: $29.85
Upside: +23.95%
Gentex
Apr 23, 2026
Maintains: Neutral
Price Target: $28$27
Current: $23.86
Upside: +13.16%
Dana Incorporated
Apr 23, 2026
Maintains: Overweight
Price Target: $39$45
Current: $38.48
Upside: +16.94%
BorgWarner
Apr 23, 2026
Maintains: Overweight
Price Target: $76$73
Current: $55.39
Upside: +31.79%
Aptiv
Apr 23, 2026
Maintains: Overweight
Price Target: $105$83
Current: $60.07
Upside: +38.17%
Adient
Apr 23, 2026
Maintains: Neutral
Price Target: $28$26
Current: $21.62
Upside: +20.26%
Avis Budget Group
Apr 23, 2026
Downgrades: Underweight
Price Target: $123$165
Current: $187.07
Upside: -11.80%
Maintains: Overweight
Price Target: $85$100
Current: $77.96
Upside: +28.27%
Maintains: Overweight
Price Target: $14$15
Current: $12.49
Upside: +20.10%
Initiates: Overweight
Price Target: $23
Current: $20.89
Upside: +10.10%
Maintains: Overweight
Price Target: $460$457
Current: $347.81
Upside: +31.39%
Maintains: Overweight
Price Target: $22$19
Current: $6.91
Upside: +174.96%
Maintains: Overweight
Price Target: $133$138
Current: $125.61
Upside: +9.86%
Maintains: Underweight
Price Target: $9$10
Current: $16.72
Upside: -40.19%
Maintains: Underweight
Price Target: $120$115
Current: $378.67
Upside: -69.63%
Downgrades: Underweight
Price Target: n/a
Current: $5.59
Upside: -
Maintains: Neutral
Price Target: $117$129
Current: $115.98
Upside: +11.23%
Reinstates: Overweight
Price Target: $20
Current: $39.80
Upside: -49.75%
Upgrades: Neutral
Price Target: $16
Current: $33.19
Upside: -51.04%